Can Rhu be renamed as KPMA chairman

Published: 2012-02-01 06:58:00

Updated: 2012-02-01 06:58:00

Attention has been drawn on whether Rhu Duk-hee , chairman of the incumbent chairman of the Korea Pharmaceutical Manufacturers Association, could be re-appointed at the next month's general meeting.

Most of KPMA executives decided to have Rhu as the next president to push the current issues un...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK